Discover common skin care ingredients that can cause allergic reactions and learn how to identify them in your products. Chronic idiopathic urticaria, also known as chronic hives or chronic ...

(BPT) – If you’ve had hives, you know how challenging they can be. But you may not know that there is more than one type of hives, or urticaria, and that treatments are available. A brief episode of ...

Experts on chronic spontaneous urticaria outline the hallmark symptoms most associated with the disease and how they fluctuate with time. What are the hallmark symptoms most associated with CSU and ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

This informational guide, part of PS's Condition Center, lays out the realities of this health concern: what it is, what it can look like, and strategies that medical experts say are proven to help.

71.9% of patients fail to follow prescribed treatment regimens due to barriers across patient, therapy, healthcare system, and socioeconomic domains. Only 33% use medications preventatively, with most ...

Hives (urticaria) are raised, itchy bumps on your skin. If you get itchy hives that come and go mostly every day for over six weeks, you might have a skin condition known as chronic spontaneous ...

A prominent feature of CSU is its association with angioedema, observed in approximately 40% to 50% of patients with CSU; around 10% of patients primarily experience angioedema as the main symptom.

Patients with CSU have an elevated risk of anxiety and depression, necessitating comprehensive management strategies. Research is focused on identifying biomarkers and clinical characteristics to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Approximately half of patients do not respond to H1 ...

In September 2025, the US Food and Drug Administration (FDA) approved Rhapsido ® (remibrutinib), an oral small molecule kinase inhibitor, for the treatment of chronic spontaneous urticaria (CSU) in ...

Please provide your email address to receive an email when new articles are posted on . Briquilimab targets c-Kit to address mast cell diseases. Patients saw substantial reductions in tryptase as ...